ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The developing landscape of diagnostic and prognostic biomarkers for spinal cord injury in cerebrospinal fluid and blood

Hulme, C. H.; Brown, S. J.; Fuller, H. R.; Riddell, J.; Osman, A.; Chowdhury, J.; Kumar, N.; Johnson, W. E.; Wright, K. T.*
SPINAL CORD2017-2DOI: 10.1038/sc.2016.174
49被引1阅读
引用收藏
分享

摘要

Study design: Review study. Objectives: The identification of prognostic biomarkers of spinal cord injury (SCI) will help to assign SCI patients to the correct treatment and rehabilitation regimes. Further, the detection of biomarkers that predict permanent neurological outcome would aid in appropriate recruitment of patients into clinical trials. The objective of this review is to evaluate the current state-of-play in this developing field. Setting: Studies from multiple countries were included. Methods: We have completed a comprehensive review of studies that have investigated prognostic biomarkers in either the blood or cerebrospinal fluid (CSF) of animals and humans following SCI. Results: Targeted and unbiased approaches have identified several prognostic biomarkers in CSF and blood. These proteins associate with cellular damage following SCI and include components from neurons, oligodendrocytes and reactive astrocytes, that is, neurofilament proteins, glial fibrillary acidic protein, Tau and S100 calcium-binding protein beta. Unbiased approaches have also identified microRNAs that are specific to SCI, as well as other cell damage-associated proteins. Conclusions: The discovery and validation of stable, specific, sensitive and reproducible biomarkers of SCI is a rapidly expanding field of research. So far, few studies have utilised unbiased approaches aimed at the discovery of biomarkers within the CSF or blood in this field; however, some targeted approaches have been successfully used. Several studies using various animal models and some with small human patient cohorts have begun to pinpoint biomarkers in the CSF and blood with putative prognostic value. An increased sample size will be required to validate these biomarkers in the heterogeneous clinical setting.

学科与关键词

关键词
NEURON-SPECIFIC ENOLASETRAUMATIC BRAIN-INJURYMYELIN-ASSOCIATED GLYCOPROTEINNEUROFILAMENT NF-HANTI-NOGO-ANEURITE OUTGROWTHFUNCTIONAL RECOVERYCHONDROITINASE ABCMASS-SPECTROMETRYSYSTEMS BIOLOGY
相关
加载中…
  • Proteomics and bioinformatics reveal insights into neuroinflammation in the acute to subacute phases in rat models of spinal cord contusion injury
    Yao, Xin-Qiang; Liu, Zhong-Yuan; Chen, Jia-Ying; Huang, Zu-Cheng; Liu, Jun-Hao; Sun, Bai-Hui; Zhu, Qing-An; Ding, Ruo-Ting*; Chen, Jian-Ting*FASEB Journal, 2021, 35(7): e21735.被引 19
  • A proteomic and phosphoproteomic landscape of spinal cord injury
    Li, Zhigang; Quan, Bingxuan; Li, Xiuyan; Xiong, Wei; Peng, Zhibin; Liu, Jingsong; Wang, Yansong*Neuroscience Letters, 2023, 814: 137449.
  • Brain morphology changes after spinal cord injury: A voxel-based meta-analysis
    Yu, Haiyang; Chen, Duanyong; Jiang, Hai; Fu, Guangtao; Yang, Yuhui; Deng, Zhantao; Chen, Yuanfeng*; Zheng, Qiujian*Frontiers in Neurology, 2022, 13: 999375.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
SPINAL CORD
发表日期
2017-02
卷期
第 55 卷, 第 2 期
页码
114-125
DOI
10.1038/sc.2016.174
语言
ENGLISH
期刊等级
Q2
成果收录
SCIE
资助标注
Midlands Centre for Spinal Injuries; Institute of Orthopaedics, RJAH Orthopaedic Hospital, Oswestry, UK

作者

  • H

    Hulme, C. H. (第一作者)

  • B

    Brown, S. J.

查看全部 9 位作者收起作者
  • F

    Fuller, H. R.

  • R

    Riddell, J.

  • O

    Osman, A.

  • C

    Chowdhury, J.

  • K

    Kumar, N.

  • J

    Johnson, W. E.

  • W

    Wright, K. T. (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417